HYTN and SNDL partnering to create GMP-compliant vape cartridges for international pharmaceutical markets
From GlobeNewswire: 2025-01-21 19:30:00
HYTN Innovations Inc. has partnered with SNDL Inc. to develop GMP-compliant vape cartridges, utilizing HYTN’s GMP-certified facility and SNDL’s resources. The collaboration aims to meet international regulatory requirements for pharmaceutical markets. Both companies are not obligated to exclusivity under the agreement, and may explore a commercial manufacturing agreement post-development. The market for GMP-compliant cannabis vape products is growing, with the UK’s medical cannabis patient numbers projected to increase by 124% and the German cannabis vape market expected to reach 966.6 million USD by 2030. HYTN focuses on GMP manufacturing to meet evolving international demands (GLOBE NEWSWIRE).
HYTN Innovations Inc. specializes in pharmaceutical-grade cannabis manufacturing and has a Drug Establishment License and EU GMP equivalent certification. SNDL Inc. is a leading vertically integrated cannabis company in Canada. GMP guidelines ensure manufacturing, testing, and quality assurance for safe products. The Pharmaceutical Inspection Co-operation Scheme (PIC/S) standardizes GMP across its 56 member countries to ensure quality and safety in pharmaceuticals. For more information, contact Elliot McKerr, CEO of HYTN Innovations Inc. at 1.866.590.9289 (GLOBE NEWSWIRE).
Read more at GlobeNewswire: HYTN and SNDL to Collaborate on GMP-Compliant Vape